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ABSTRACT Amyloids are associated with a number of protein misfolding disorders, including prion diseases. In this study, we
used single-molecule force spectroscopy to characterize the nanomechanical properties and molecular structure of amyloid
ﬁbrils formed by human prion protein PrP90-231. Force-extension curves obtained by speciﬁc attachment of a gold-covered
atomic force microscope tip to engineered Cys residues could be described by the worm-like chain model for entropic elasticity
of a polymer chain, with the size of the N-terminal segment that could be stretched entropically depending on the tip attachment
site. The data presented here provide direct information about the forces required to extract an individual monomer from the
core of the PrP90-231 amyloid, and indicate that the b-sheet core of this amyloid starts at residue ;164–169. The latter ﬁnding
has important implications for the ongoing debate regarding the structure of PrP amyloid.
INTRODUCTION
Transmissible spongiform encephalopathies (TSEs), more
commonly referred to as prion diseases, are a group of fatal
neurodegenerative disorders that affect several mammalian
species and include bovine spongiform encephalopathy in
cattle, scrapie in sheep, chronic wasting disease in cervids,
and Creutzfeldt-Jakob’s disease and kuru in humans (1–6).
These devastating brain-wasting diseases are known to arise
through sporadic, inherited, or infectious mechanisms, and in
all cases result in a neuropathology that shows characteristic
spongiform degeneration and astrogliosis (2,4,5). Like a
number of other neurodegenerative disorders, such as Alz-
heimer’s, Parkinson’s, and Huntington’s diseases, prion
diseases are associated with cerebral accumulation of ab-
normal protein deposits (1–8). In many (though not all) cases,
these deposits are largely composed of amyloid ﬁbrils—
highly ordered protein aggregates that show a characteristic
‘‘cross-b’’ x-ray diffraction pattern (7). In the case of TSEs,
these deposits result from conformational conversion of
normal cellular prion protein, PrPC, to an abnormal isoform,
PrPSc. According to the protein-only hypothesis, the trans-
mission of TSEs does not require nucleic acids, and PrPSc
itself represents the infectious pathogen that self-replicates by
binding to PrPC and templating its conversion to the PrPSc
state (1–6). This model is gaining growing acceptance, par-
ticularly in the light of recent successes in generating infec-
tious PrPSc in vitro (9–11).
Cellular human PrPC is a 209 residuemembrane-associated
protein, with a C-terminally attached glycosylphosphatidylinositol
anchor and two Asn-linked glycosylation sites (2–5). High-
resolution NMR structures of recombinant PrP, a non-
glycosylated model of PrPC, reveal a ﬂexible N-terminal
region and a C-terminal globular domain containing three
a-helices and two short b-strands, with a disulﬁde bond
bridging helices 2 and 3 (12–14). Upon conversion of
monomeric PrPC to PrPSc aggregate, the protein becomes
insoluble in nonionic detergents and acquires remarkable
resistance to proteinase K digestion, with the PK-resistant
core typically starting at residue ;90 (1–4). Furthermore,
low-resolution optical spectroscopic data indicate that, in
contrast to PrPC, PrPSc is rich in b-sheet structure (15,16).
Given that higher-resolution structural studies with brain-
derived protein deposits present enormous experimental
challenges and the molecular structure of PrPSc associated
with TSE infectivity is still poorly deﬁned, a number of
laboratories have focused on PrPSc-mimicking amyloid
ﬁbrils formed by the recombinant prion protein. In particular,
recent structural studies using H/D exchange (17) and site-
directed spin labeling (18) indicate that the stable H-bonded
‘‘b-core’’ of the recombinant PrP ﬁbril encompasses residues
;160–220, and these residues form single-molecule layers
that stack on top of one another with parallel, in-register
alignment of b-strands. Furthermore, the entire region N-ter-
minal to this amyloid core does not appear to possess a stable
secondary structure (17,18).
Other important questions relate to the energetics of am-
yloid ﬁbril assembly, the stability of these structures, and
their nanomechanical properties. Recently, single-molecule
force spectroscopy using an atomic force microscope (AFM)
has emerged as a powerful tool for studying the nano-
mechanical and thermodynamic properties of proteins and
other biomolecules (19). In this study we adapted this ap-
proach to probe amyloid ﬁbrils formed by the recombinant
polypeptide corresponding to human prion protein 90-231
(huPrP90-231). This C-terminal region of PrP appears to play
a critical role in TSE pathogenesis. It encompasses the entire
sequence of the protease-resistant fragment of aggregate
PrPSc found in diseased brain, contains all point mutations
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associated with hereditary prion disorders, and is sufﬁcient
for propagation of the disease (2,4).
MATERIALS AND METHODS
Generation of the Cys variants of huPrP90-231
and protein puriﬁcation
Cysteine was incorporated at positions 103 and 90 of huPrP90-231 by site-
directed mutagenesis, and proteins were expressed and subjected to our
puriﬁcation and refolding protocol as previously described (20). The cor-
rectness of folding of the Cys variants was veriﬁed by far-UV circular di-
chroism spectroscopy.
Preparation of amyloid ﬁbrils
Amyloid ﬁbrils were obtained by incubation of the prion protein at 37Cwith
gentle rotation essentially as described previously (20). To prevent inter-
molecular disulﬁde formation between introduced Cys residues, the disul-
ﬁde-speciﬁc reducing agent Tris(2-carboxyethyl)phosphine hydrochloride
(TCEP) was added to the conversion buffer at a concentration of 1 mM.
AFM imaging and force measurements
For AFM experiments, 5 ml of ﬁbrilized protein were deposited on freshly
cleaved mica and left to adsorb for 1 min. Afterward, the sample was rinsed
three times with 50 ml of 50 mM phosphate buffer, pH 6.4, to remove traces
of TCEP. Imaging and force measurements were performed on a Nanoscope
IV AFM (Veeco, Santa Barbara, CA) using an E-scanner (calibrated on a
standard grid) and gold-covered tips mounted on a rectangular cantilever
with a nominal spring constant of 0.027 N/m (Olympus Bio-Lever BL-RC
150VB). These tips were calibrated using the thermal tune procedure on a
PicoForce MultiMode AFM (Veeco). Some experiments (as indicated in the
text) were performed using oxide-sharpened Si3N4 tips attached to a trian-
gular cantilever with a spring constant of 0.06 N/m (NanoProbe, Santa
Barbara, CA). A ﬂuid cell without O-ring was ﬁlled with 50 mM phosphate
buffer, pH 6.4, and the sample was scanned in tapping mode. In this mode,
individual contact events between the tip and sample are very short, on the
order of tenths of milliseconds at typical oscillation frequencies (;8.5–9.0
kHz). We further decreased the contact time and interaction forces by ad-
justing the ‘‘amplitude setpoint’’ to the highest possible value at which the
image was still stable. Next, we zoomed in on the spot of interest (increasing
the magniﬁcation in two to three consecutive steps to reduce mechanical drift
and position the tip precisely over a ﬁbril), switched to force mode, and
collected force-distance curves on the selected spot. The contact force used
during these measurements was limited to 0.3–0.4 nN to minimize any
nonspeciﬁc adsorption of protein to the tip.
Force-curves analysis
The force curves were analyzed according to the worm-like chain (WLC)
model for elasticity of a polymer chain, using the equation: F(x) ¼ (kT/p)
[0.25(1 x/Lc)20.251 x/Lc] (21), where F(x) is the force at position x, p
is the persistent length, kT is the thermal energy, and Lc is the contour length.
The loading rate dependency was ﬁt to the equation: F ¼ (kT/Dx)ln [r/((kT/
Dx)koff)] (19), where F is the measured force, r is the loading rate, Dx is the
distance between the ground and transition state, koff is the natural off-rate of
the system, and kT is the thermal energy.
RESULTS
Our initial attempts to perform single-molecule measurements
with huPrP90-231 amyloid deposited on amica surface relied
on nonspeciﬁc adsorption of protein to the AFM tip. How-
ever, the resulting force spectra showed great variability
between individual measurements (see Fig. 1). This varia-
bility, which most likely results from random and/or multiple
attachment sites of the protein to the tip, precluded any
meaningful interpretation of the force-distance curves. To
overcome this problem, we functionalized the protein by
replacing Ser at position 103 with Cys, and performed force
measurements using a gold-coated AFM tip. The thiol group
of Cys is known to form a covalent bond with gold, facili-
tating single-molecule AFM experiments with systems
requiring a well-deﬁned attachment site (22,23). Placement
of the engineered Cys residue near the N-terminus of
huPrP90-231 was dictated by recent H/D exchange and site-
directed spin labeling data indicating that the entire region of
the protein N-terminal to residue;160 is outside the amyloid
core (17,18). Thus, residue 103 should be easily accessible to
the Au-covered AFM tip.
For each sample preparation, we ﬁrst imaged the surface to
visualize ﬁbrils (Fig. 2 a). To minimize potential collection of
protein molecules on the tip surface, we performed AFM
imaging in a tapping mode using the parameters that mini-
mize the contact time and interaction force. Next, we zoomed
in on the selected spot and pushed the tip onto the ﬁbril with a
contact force of 0.3–0.4 nN for ;0.5 s, and recorded force
spectra during retraction of the tip as described in Materials
and Methods. A large proportion (;35%) of force-distance
curves recorded for the Cys-mutant probed with the gold-
coated tip had characteristics typical of elastic stretching (Fig.
2 b). This is in sharp contrast to the irregular and poorly
reproducible curves observed for the wild-type protein or the
S103C variant probed with Si3N4 tip, where the elastic
stretching events were very rare, corresponding to ,5% of
FIGURE 1 Examples of force curves obtained in experiments relying on
nonspeciﬁc adsorption of wild-type huPrP90-231 (without engineered Cys
at position 103) to the AFM tip.
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the measurements. The elastic stretching-type curves for the
Cys-mutant probed with a gold-coated tip are reminiscent of
force extension spectra observed for unfolding of individual
units of modular proteins such as titin (24). These curves
could be well described by the WLC model for entropic
elasticity of a polymer chain. A representative ﬁt of experi-
mental data according to this model is shown in Fig. 2 c.
What is the nature of molecular interactions that give rise
to the force curves observed during pulling of PrP90-231
from amyloid ﬁbrils? The elastic character of these curves
implies that the segment of the polypeptide chain between the
covalent attachment site to the tip (residue 103) and the
b-sheet core of the amyloid must be able to undergo purely
entropic stretching, strongly suggesting that this region of the
protein is largely disordered (see Discussion). Further re-
traction of the tip resulted in a ‘‘rupture’’ of the system that
occurred as an ‘‘all-or none’’ event (Fig. 2 b). Since the force
of this rupture is one order of magnitude lower than the
strength of a covalent Au-Cys bond [;1.4 nN (25)], and
given the control experiments described below, we conclude
that this latter event most likely represents mechanical ex-
traction of the prion protein from the core of the amyloid ﬁbril
(Fig. 3). We also considered the possibility that, rather than
extracting individual monomers from the ﬁbril, our force
measurements correspond to lifting of the whole ﬁbril from
the mica surface. However, simple calculations of attractive
van der Waals forces can be made using the formula for the
force of interaction between a cylinder and ﬂat surface (26).
Using the Hamaker constant that is typical for protein-surface
interactions in electrolyte solution (4 3 1021 J (27)), and a
separation distance of 0.4 nm (28), we estimate that ﬁbrils
attach to mica with a van der Waals force of ;7 pN per
nanometer (assuming a ﬁbril radius of 5 nm). Therefore, even
for ﬁbrils as short as 500 nm, the attractive force is estimated
to be;3.5 nN (i.e., much higher than those registered in our
experiments), making the possibility that our measurements
correspond to lifting of the whole ﬁbril highly unlikely.
Consistent with this estimate, strong nonspeciﬁc attachment
of amyloid ﬁbrils to a mica surface was found in previous
studies with Ab peptide, as indicated by a similar force re-
sponse in experiments using ﬁbrils attached nonspeciﬁcally
or chemically cross-linked to the surface (29).
One source of potential artifacts in interpretation of our
experimental data is the relatively large radius of curvature
inherent to the gold-coated tip, which raises the possibility
that multiple PrP monomers covalently attach during indi-
vidual pulling events. To address this issue, force measure-
ments were repeated using ﬁbrils in which the Cys-containing
mutant was comixed (at a 1:3 ratio) with the wild-type pro-
tein. Such a dilution of the Cys-variant would be expected to
greatly reduce the probability for the attachment of multiple
molecules. For these comixed ﬁbrils, the frequency of spe-
ciﬁc attachment was reduced to;7–10%; however, the force
histogram was nearly identical to that in Fig. 4 a (data not
shown for brevity), strongly indicating that the elastic
stretching curves observed represent a single-molecule event.
Indeed, the frequency of speciﬁc events in force measure-
ments on the order of ;10% is usually considered as indic-
ative of a single-molecule level manipulation (30).
A potential complication of the measurements presented
here is that PrP monomers extracted in earlier cycles re-
mained attached to the gold-coated tip throughout the
experiment. In principle, this could inﬂuence force mea-
surements since many pulling events are monitored with a
single tip. However, our analysis revealed that the registered
forces do not show variation with time (i.e., there is no dif-
ference between elastic curves observed in the ﬁrst stretch
cycle (with a new tip) and subsequent ones). To further probe
this issue, we examined the interaction between Au-covered
FIGURE 2 AFM image and force-
extension curves for S103C huPrP90-
231 amyloid ﬁbrils. (a) AFM height
image obtained in tapping mode.
Z-scale is 10 nm. (b) Superposition of
three representative force-extension
curves showing elastic stretching be-
havior (at a pulling rate of 9.4 nN/s). (c)
A ﬁt of one of these curves according to
the WLC model with a persistence
length of 0.4 nm. The contour length
derived from this particular ﬁt is
24.2 nm.
FIGURE 3 Schematic representation of the experiment, with the core of
amyloid ﬁbril depicted in gray, and blue lines representing intermolecular
hydrogen bonds between the monomers. (a) The gold-covered AFM tip
attaches covalently to C-103 on one of the monomers of the mica-adsorbed
amyloid. (b) Retraction of the tip results in elastic stretching of the monomer
between residue 103 and the beginning of the amyloid core region (black
line). (c) When the pulling force exceeds a critical value, the monomer is
extracted from the amyloid as an ‘‘all-or-none’’ event. This cartoon is for
illustrative purposes only; it does not imply any speciﬁc structure of the PrP
amyloid core, or any knowledge of pulling geometry in these experiments.
The relative dimensions of the tip and protein molecules are not to scale.
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tips and mica covered with S103C PrP monomers, as well as
the interaction between the free mica surface and the tip
preincubated in the protein monomer solution. In both cases,
we found that only a miniscule fraction (,2%) of the force
curves showed any elastic behavior. Altogether, these control
experiments strongly indicate that the force-distance curves
shown in Fig. 2 indeed represent single-molecule events in
which elastic stretching precedes removal of PrP monomers
from the amyloid.
The histogram of forces recorded in over 100 measure-
ments resulting in elastic curves, such as those exempliﬁed in
Fig. 2, shows a well-deﬁned peak at 1156 5 pN (Fig. 4 a). As
discussed above, we attribute this force to mechanical ex-
traction of an individual prion protein monomer from the
amyloid ﬁbril. The forces required to trigger mechanical
unfolding of individual domains of modular monomeric
proteins are known to depend on the rate at which the force is
applied (31–33). A similar dependency on the loading rate
was found in this study with the PrP90-231 amyloid (Fig. 5).
Analysis of the force versus loading rate plot, according to
the formalism of Evans and Ritchie (34) allowed us to esti-
mate the rate of the reaction corresponding to PrP monomer
dissociation from the amyloid at zero force (koff) as 2.4 3
102 s1, and the position of the transition state (distance in
conﬁgurational space from the native geometry to the tran-
sition state of the monomer extraction event) as Dx ¼ 0.38
nm. The latter value is remarkably similar to those reported
for the transition state in mechanical unfolding of modular
b-sheet proteins (31–33,35).
The contour-length histogram derived from data analysis
for C-103 huPrP90-231 according to the WLC model shows
a well-deﬁned maximum around 24–25 nm (Fig. 4 b),
implying that ;63–66 residues can be stretched entropically
before the protein is extracted from the amyloid core of
PrP90-231 ﬁbrils (assuming 0.38 nm per residue in a fully
extended conformation). The ability to stretch entropically
strongly suggests that the region encompassing these resi-
dues lacks any stable, systematically H-bonded structure.
Since the protein is covalently attached to the tip at residue
103, this would place the beginning of the H-bonded core of
the amyloid at residue;166–169. To further test this model,
we repeated the force measurements using a huPrP90-231
variant in which the Cys residue for speciﬁc attachment to the
gold-coated tip was moved N-terminally to position 90. The
histogram of forces recorded for C-90 huPrP90-231 amyloid
ﬁbrils has a maximum at precisely the same value as observed
FIGURE 4 Histograms of forces and contour lengths (at
a tip retraction rate of 9.4 nN/s) for C-103 huPrP90-231
(a and b) and C-90 huPrP90-231 (c and d). (a and c) Force-
frequency histograms. (b and d) Contour length-frequency
histograms. Only experiments that show an elastic stretch-
ing behavior are included in this analysis.
FIGURE 5 Pulling-speed dependence of forces measured for extraction of
individual monomers from huPrP90-231 amyloid ﬁbrils.
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for protein with Cys at position 103 (Fig. 4, a and c).
However, the contour length is signiﬁcantly longer, with a
maximum in the histogram around 28–29 nm (Fig. 4 d). This
contour length (as compared to 24–25 nm in the case of
C-103 huPrP90-231) indicates that, when the protein is at-
tached to the tip at position 90, ;74–76 residues can be
stretched entropically, placing the beginning of the H-bonded
core region of the amyloid at residue;164–166. A very good
correlation between the number of residues that can be
stretched entropically and the tip attachment site (and thus a
very consistent estimate for the beginning of the amyloid
core) provides an important internal control, validating our
interpretation of force spectroscopy data.
DISCUSSION
In this study, we used AFM to probe the nanomechanical
properties of amyloid ﬁbrils formed by recombinant human
prion protein 90-231. Numerous control experiments
strongly indicate that the force-distance curves obtained in
our experiments represent single-molecule events in which
elastic stretching precedes removal of the PrP monomer from
the amyloid (Fig. 3). This force of mechanical extraction of
the monomer from the amyloid ﬁbril (1156 5 pN at a pulling
rate of 9.4 nN/s) is within the range of values reported for
mechanical unfolding (at comparable pulling rates) of indi-
vidual units of modular b-sheet proteins, such as different
domains of titin (80-300 pN) (31–33,35) or tenascin (;137
pN) (36), and is signiﬁcantly higher than those typically
observed for the unfolding of a-helical proteins (33,37,38)
(e.g., 15–25 pN for spectrin (37) or 64 pN for lysozyme (38)).
Recent studies indicate that the mechanical resistance of
b-sheet proteins is strongly dependent on pulling geometry
(23,39–42) (the direction of the applied force), with longi-
tudinal ‘‘shearing’’ of b-strands generally requiring much
larger forces than orthogonal ‘‘peeling’’ (39,40). For in-
stance, in the case of an all-b protein, E2lip3, the force
needed for mechanical unfolding was as high as ;180 pN
when the protein was subjected to shearlike extension,
dropping below the detection limit of AFM (;15 pN) when
peeling force was applied (39). A similar dependence on
extension directionality was reported for proteins such as
ubiquitin (41) and GFP (42). The experimental design of this
study did not allow us to control the pulling geometry.
However, in the context of data reported for mechanical
unfolding of modular b-sheet proteins, the magnitude of
forces measured here is surprisingly low, especially given the
size of the H-bonded core of PrP amyloid (17,18). This
suggests that the extraction of the monomer from amyloid
ﬁbrils in our experiments likely occurs by a mechanism other
than a simple shearlike mechanism.
Perhaps the most important ﬁnding of this study is that the
N-terminal part of huPrP90-231 in amyloid ﬁbrils up to res-
idue;164–169 is able to undergo purely entropic stretching,
indicating a largely disordered structure in this region of the
protein. This has important implications for the ongoing
debate regarding the structure of PrP amyloid. The models
frequently discussed in the literature postulate that the b-core
region of the amyloid maps to the N-terminal part of PrP90-
231 (residues;90–175 and 116–164 for the b-helix (43) and
spiral model (44), respectively), with at least two C-terminal
a-helices remaining largely preserved. The experimental data
presented here are clearly at odds with both of these largely in
silico models, since such an N-terminal location of the core
region would not allow for an entropic stretching as observed
in the force-extension curves. On the other hand, single-
molecule AFMmeasurements correlate remarkably well with
recent structural studies that used hydrogen/deuterium ex-
change and site-directed spin labeling (17,18). Both of these
studies indicate that amyloid ﬁbril formation involves major
refolding of the entire a-helical region of PrP90-231, map-
ping the b-sheet core of the amyloid to the C-terminal part of
the protein starting at residue ;161–169.
Although recombinant PrP amyloid ﬁbrils similar to those
used in this study have been reported to induce a neurological
disease in transgenic mice overexpressing N-terminally
truncated PrP (9), the infectivity titer was exceedingly low,
suggesting that perhaps only a tiny proportion of these syn-
thetic aggregates represent the infectious entity. Furthermore,
TSE prions are known to form different strains, and this strain
variability is believed to be encoded by distinct conforma-
tions of PrPSc (2–6). Clearly, the recombinant ﬁbrils used in
this study represent only a small part of the spectrum of the
misfolded PrP conformers—one that does not fully recapit-
ulate structural properties of the highly infectious TSE agent.
Nevertheless, studies with these synthetic ﬁbrils are funda-
mentally important for guiding the design and interpretation
of future, experimentally far more challenging studies with
brain-derived PrPSc.
Previous attempts to use force spectroscopy in amyloid
research were limited to probing the global properties of
these biologically important but poorly understood structures
(29,45,46). In particular, studies with Ab amyloid ﬁbrils
(29,45) reported complex force curves featuring a nonlinear
elastic response (attributed by the authors to ‘‘elasticity of the
b-sheet that has been liberated from its lateral conﬁnement
within the ﬁbril’’) and long force plateaus (attributed to the
‘‘unzipping of b-sheets from the ﬁbril’’). In this study, with
PrP amyloid, we did not observe any such complex force
curves. The different response types observed in force mea-
surements with Ab ﬁbrils is not surprising, given that the
disordered part of the Ab peptide outside the H-bonded
amyloid core (i.e., available for entropic stretching) is very
short (47). Furthermore, apart from using an entirely different
protein, the other major difference between the previous
studies with Ab peptide (29,45) and the present study with
PrP is methodological. Whereas the experiments with Ab
ﬁbrils reported on more-global events that occur upon non-
speciﬁc attachment of the protein to the tip (presumably at
multiple sites), the work presented here exploited speciﬁc
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attachment to an engineered recognition site, providing direct
information about the energetics and nanomechanical prop-
erties of amyloid ﬁbrils at a single-molecule level. The ap-
proach employed herein should be applicable for probing a
wide range of fundamental questions in amyloid research,
including those related to the mechanism of ﬁbril assembly
and stability, as well as the structural and/or thermodynamic
basis of prion and amyloid strain variability (2,48).
This work was supported by National Institutes of Health grants NS 44158
and NS 38604 (to W.K.S.).
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